• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度与新冠病毒疾病死亡率相关的社会人口统计学和临床因素:一项回顾性研究

Sociodemographic and Clinical Factors Associated with COVID-19 Mortality in India: a Retrospective Study.

作者信息

Parashar Lokesh, Shekhar Himanshu, Arya Hina, Vig Shankar Lal, Prasad Jagdish, Meshram Girish Gulab

机构信息

Department of Statistics, Amity School of Applied Sciences, Amity University, Jaipur 303002, Rajasthan, India.

Department of Community Medicine, Shri Atal Bihari Vajpayee Government Medical College, Chhainsa, Faridabad 121001, Haryana, India.

出版信息

Acta Inform Med. 2025;33(1):23-29. doi: 10.5455/aim.2024.33.23-29.

DOI:10.5455/aim.2024.33.23-29
PMID:40223849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11986342/
Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic significantly impacted global health, with India experiencing one of the highest case and death tolls. However, data specific to India's sociodemographic and clinical factors influencing COVID-19 mortality remains limited.

OBJECTIVE

This study aimed to identify sociodemographic and clinical factors associated with COVID-19 mortality in India.

METHODS

This retrospective, cross-sectional study analyzed medical records of 4961 adult COVID-19 patients admitted to a tertiary care center in North India, from April 2020 to December 2021. Sociodemographic and clinical data were captured using a structured proforma. Univariate analysis (chi-square test) and Kaplan-Meier survival analysis were performed to identify factors associated with mortality.

RESULTS

Of the 4961 patients, 557 (11.2%) died, and 4404 (88.8%) survived. Increased age, rural residency, professional occupation, and comorbidities (diabetes and hypertension), multimorbidity, increased disease severity, cold and flu symptoms, breathlessness, and the need for intensive care unit (ICU) admission and ventilator support were significantly (P <0.05) associated with higher COVID-19 mortality. While some associations were observed with sociodemographic factors like religion, education level, and monthly family income in univariate analysis, these were not significant in survival analysis.

CONCLUSION

In this cohort of COVID-19 patients in India, advanced age, rural residency, professional occupation, comorbidities, multimorbidity, severe symptoms, and the need for ICU admission and ventilator support were identified as significant risk factors for mortality. Early identification and intervention for these high-risk groups may improve survival rates.

摘要

背景

2019年冠状病毒病(COVID-19)大流行对全球健康产生了重大影响,印度是病例数和死亡人数最多的国家之一。然而,关于影响印度COVID-19死亡率的社会人口统计学和临床因素的具体数据仍然有限。

目的

本研究旨在确定印度与COVID-19死亡率相关的社会人口统计学和临床因素。

方法

这项回顾性横断面研究分析了2020年4月至2021年12月期间入住印度北部一家三级护理中心的4961例成年COVID-19患者的病历。使用结构化表格收集社会人口统计学和临床数据。进行单因素分析(卡方检验)和Kaplan-Meier生存分析以确定与死亡率相关的因素。

结果

在4961例患者中,557例(11.2%)死亡,4404例(88.8%)存活。年龄增加、农村居住、职业、合并症(糖尿病和高血压)、多种合并症、疾病严重程度增加、感冒和流感症状、呼吸困难以及需要入住重症监护病房(ICU)和呼吸机支持与较高的COVID-19死亡率显著相关(P<0.05)。虽然在单因素分析中观察到一些与宗教、教育水平和家庭月收入等社会人口统计学因素的关联,但在生存分析中这些并不显著。

结论

在印度的这一队列COVID-19患者中,高龄、农村居住、职业、合并症、多种合并症、严重症状以及需要入住ICU和呼吸机支持被确定为死亡率的重要危险因素。对这些高危人群进行早期识别和干预可能会提高生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/11986342/16e99bf6060e/AIM-33-23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/11986342/e3f8eb71a220/AIM-33-23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/11986342/16e99bf6060e/AIM-33-23-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/11986342/e3f8eb71a220/AIM-33-23-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea57/11986342/16e99bf6060e/AIM-33-23-g002.jpg

相似文献

1
Sociodemographic and Clinical Factors Associated with COVID-19 Mortality in India: a Retrospective Study.印度与新冠病毒疾病死亡率相关的社会人口统计学和临床因素:一项回顾性研究
Acta Inform Med. 2025;33(1):23-29. doi: 10.5455/aim.2024.33.23-29.
2
Risk Factors associated with COVID-19 Patients in India: A Single Center Retrospective Cohort Study.印度 COVID-19 患者的相关风险因素:一项单中心回顾性队列研究。
J Assoc Physicians India. 2023 Jun;71(6):11-12. doi: 10.5005/japi-11001-0263.
3
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.新型冠状病毒肺炎患者的体重指数、患者特征与肥胖相关合并症之间的关联:一项前瞻性队列研究。
Obes Res Clin Pract. 2023 Jan-Feb;17(1):47-57. doi: 10.1016/j.orcp.2022.12.003. Epub 2022 Dec 20.
4
Clinical presentation and mortality risk factors for COVID-19 among diabetic patients in a tertiary care center in South India.印度南部一家三级护理中心的糖尿病患者感染 COVID-19 的临床表现和死亡风险因素。
Indian J Tuberc. 2022 Oct;69(4):496-502. doi: 10.1016/j.ijtb.2021.08.015. Epub 2021 Aug 14.
5
Clinical Features and Outcomes of Patients With COVID-19 Infection and Acute Kidney Injury Requiring Hemodialysis in an Intensive Care Unit: A Retrospective Study From a Tertiary Care Center in Eastern India.重症监护病房中需要血液透析的新型冠状病毒肺炎感染合并急性肾损伤患者的临床特征及预后:来自印度东部一家三级医疗中心的回顾性研究
Cureus. 2024 Dec 9;16(12):e75363. doi: 10.7759/cureus.75363. eCollection 2024 Dec.
6
Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients.非合并症、合并症和多重合并症住院COVID-19患者C反应蛋白水平的比较分析。
BMC Infect Dis. 2025 Jan 14;25(1):59. doi: 10.1186/s12879-024-10314-2.
7
Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study.巴基斯坦新冠肺炎住院患者的临床表现、合并症及预后:回顾性观察研究
JMIR Public Health Surveill. 2021 Dec 14;7(12):e32203. doi: 10.2196/32203.
8
Clinical profile and risk factors for mortality among COVID-19 inpatients at a tertiary care centre in Bengaluru, India.印度班加罗尔一家三级护理中心的 COVID-19 住院患者的临床特征和死亡风险因素。
Monaldi Arch Chest Dis. 2021 May 17;91(3). doi: 10.4081/monaldi.2021.1724.
9
Comorbidities associated with risk of ICU admission in elderly patients with COVID-19: Data from academic hospital in Saudi Arabia.与 COVID-19 老年患者 ICU 入院风险相关的合并症:来自沙特阿拉伯学术医院的数据。
Medicine (Baltimore). 2022 Sep 30;101(39):e30799. doi: 10.1097/MD.0000000000030799.
10
Comparison of Clinical Characteristics and Outcome of Critically Ill Patients Admitted to Tertiary Care Intensive Care Units in India during the Peak Months of First and Second Waves of COVID-19 Pandemic: A Retrospective Analysis.印度第一波和第二波新冠疫情高峰月期间三级医疗重症监护病房收治的危重症患者临床特征及结局比较:一项回顾性分析
Indian J Crit Care Med. 2021 Dec;25(12):1349-1356. doi: 10.5005/jp-journals-10071-24046.

本文引用的文献

1
Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization, 2020 to 2023.2020年至2023年新冠病毒肺炎住院治疗后的长期死亡率及再入院情况的城乡差异
Open Forum Infect Dis. 2024 Apr 5;11(5):ofae197. doi: 10.1093/ofid/ofae197. eCollection 2024 May.
2
Occupation and COVID-19: Lessons From the Pandemic.职业与 COVID-19:大流行带来的教训。
J Allergy Clin Immunol Pract. 2024 Aug;12(8):1997-2007.e2. doi: 10.1016/j.jaip.2024.04.022. Epub 2024 Apr 20.
3
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study.
识别和未识别的 SARS-CoV-2 感染的危险因素:前瞻性城乡流行病学(PURE)研究的血清流行病学分析。
Microbiol Spectr. 2024 Feb 6;12(2):e0149223. doi: 10.1128/spectrum.01492-23. Epub 2024 Jan 12.
4
Low education predicts large increase in COVID-19 mortality: the role of collective culture and individual literacy.受教育程度低预示着 COVID-19 死亡率的大幅上升:集体文化和个体文化素养的作用。
Public Health. 2023 Aug;221:201-207. doi: 10.1016/j.puhe.2023.06.016. Epub 2023 Jun 21.
5
Risk Factors associated with COVID-19 Patients in India: A Single Center Retrospective Cohort Study.印度 COVID-19 患者的相关风险因素:一项单中心回顾性队列研究。
J Assoc Physicians India. 2023 Jun;71(6):11-12. doi: 10.5005/japi-11001-0263.
6
Predictors of Mortality among Patients Hospitalized with COVID-19 during the First Wave in India: A Multisite Case-Control Study.印度第一波 COVID-19 住院患者死亡率的预测因素:一项多地点病例对照研究。
Am J Trop Med Hyg. 2023 Mar 13;108(4):727-733. doi: 10.4269/ajtmh.22-0705. Print 2023 Apr 5.
7
Comorbidities, multimorbidity and COVID-19.合并症、多重疾病与2019冠状病毒病
Nat Med. 2023 Feb;29(2):334-343. doi: 10.1038/s41591-022-02156-9. Epub 2023 Feb 16.
8
Clinical and treatment factors associated with the mortality of COVID-19 patients admitted to a referral hospital in Indonesia.印度尼西亚一家转诊医院收治的新冠肺炎患者死亡率相关的临床和治疗因素。
Lancet Reg Health Southeast Asia. 2023 Apr;11:100167. doi: 10.1016/j.lansea.2023.100167. Epub 2023 Feb 9.
9
Risk Factors of Severity and Mortality Among COVID-19 Patients: A Prospective Observational Study From a Tertiary Care Center.新型冠状病毒肺炎患者严重程度和死亡率的危险因素:一项来自三级医疗中心的前瞻性观察研究
Cureus. 2022 Aug 9;14(8):e27814. doi: 10.7759/cureus.27814. eCollection 2022 Aug.
10
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.COVID-19 与合并症:风险、协同作用和临床结局。
Front Immunol. 2022 May 27;13:890517. doi: 10.3389/fimmu.2022.890517. eCollection 2022.